These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38332247)

  • 1. The clinical significance of calcium/magnesium ratio in primary hyperparathyroidism: unveiling a clinical association.
    Köroğlu EY; Tam AA; Fakı S; Tural Balsak B; Edis Özdemir FA; Özdemir D; Topaloğlu O; Ersoy R; Çakır B
    Hormones (Athens); 2024 Sep; 23(3):567-574. PubMed ID: 38332247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypomagnesuria is Associated With Nephrolithiasis in Patients With Asymptomatic Primary Hyperparathyroidism.
    Saponaro F; Marcocci C; Apicella M; Mazoni L; Borsari S; Pardi E; Di Giulio M; Carlucci F; Scalese M; Bilezikian JP; Cetani F
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32369583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normocalcaemic primary hyperparathyroidism: is nephrolithiasis more common than osteoporosis?
    Wu KCJ; Anpalahan M
    Intern Med J; 2023 Jan; 53(1):112-118. PubMed ID: 34435736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Could there be a role of serum zonulin increase in the development of hypercalcemia in primary hyperparathyroidism.
    Korkmaz H; Sirin FB; Torus B
    Endocrine; 2021 Apr; 72(1):234-238. PubMed ID: 32989570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephrolithiasis and bone involvement in primary hyperparathyroidism.
    Silverberg SJ; Shane E; Jacobs TP; Siris ES; Gartenberg F; Seldin D; Clemens TL; Bilezikian JP
    Am J Med; 1990 Sep; 89(3):327-34. PubMed ID: 2393037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between hypomagnesemia and severity of primary hyperparathyroidism: a retrospective study.
    Na D; Tao G; Shu-Ying L; Qin-Yi W; Xiao-Li Q; Yong-Fang L; Yang-Na O; Zhi-Feng S; Yan-Yi Y
    BMC Endocr Disord; 2021 Aug; 21(1):170. PubMed ID: 34416890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of vitamin D deficiency on clinical, biochemical and metabolic parameters in primary hyperparathyroidism.
    Şengül Ayçiçek G; Aydoğan Bİ; Şahin M; Emral R; Erdoğan MF; Güllü S; Başkal N; Çorapçıoğlu D
    Endocrinol Diabetes Nutr (Engl Ed); 2023 Jan; 70(1):56-62. PubMed ID: 36764749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of Nephrolithiasis, Osteoporosis, and Mortality in Primary Hyperparathyroidism.
    Reid LJ; Muthukrishnan B; Patel D; Seckl JR; Gibb FW
    J Clin Endocrinol Metab; 2019 Sep; 104(9):3692-3700. PubMed ID: 30916764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of hypophosphatemia in the clinical management of primary hyperparathyroidism.
    Düğer H; Bostan H; Gül Ü; Uçan B; Hepşen S; Sakız D; Akhanlı P; Çakal E; Kızılgül M
    J Endocrinol Invest; 2023 Sep; 46(9):1935-1940. PubMed ID: 36929458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender differences in the presentation, course and outcomes of primary hyperparathyroidism.
    Dadon T; Tsvetov G; Levi S; Gorshtein A; Slutzky-Shraga I; Hirsch D
    Maturitas; 2021 Mar; 145():12-17. PubMed ID: 33541557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of forearm bone mineral density evaluation in determining surgical indications in primary hyperparathyroidism.
    Piskinpasa H; Dogansen SC; Metin D; Sahbaz NA; Esen A; Bozkur E; Aydin H; Turgut S; Pamuk N; Mert M; Cakir İ
    Ann Endocrinol (Paris); 2023 Feb; 84(1):8-13. PubMed ID: 36252847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D in Primary Hyperparathyroidism: Effects on Clinical, Biochemical, and Densitometric Presentation.
    Walker MD; Cong E; Lee JA; Kepley A; Zhang C; McMahon DJ; Silverberg SJ
    J Clin Endocrinol Metab; 2015 Sep; 100(9):3443-51. PubMed ID: 26079779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of clinical parameters and parathyroid scintigraphy for asymptomatic primary hyperparathyroidism.
    Ning Y; Chen D; Huang Z; Lou C
    Hell J Nucl Med; 2020; 23(2):148-157. PubMed ID: 32716406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative evaluation of hyperparathyroidism: the role of dual-phase parathyroid scintigraphy and ultrasound imaging.
    Sukan A; Reyhan M; Aydin M; Yapar AF; Sert Y; Canpolat T; Aktas A
    Ann Nucl Med; 2008 Feb; 22(2):123-31. PubMed ID: 18311537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NEPHROLITHIASIS IN PRIMARY HYPERPARATHYROIDISM: A COMPARISON BETWEEN SILENT AND SYMPTOMATIC PATIENTS.
    Castellano E; Attanasio R; Latina A; Visconti GL; Cassibba S; Borretta G
    Endocr Pract; 2017 Feb; 23(2):157-162. PubMed ID: 27819765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of obesity on the presentation of primary hyperparathyroidism.
    Tran H; Grange JS; Adams-Huet B; Nwariaku FE; Rabaglia JL; Woodruff SL; Holt SA; Maalouf NM
    J Clin Endocrinol Metab; 2014 Jul; 99(7):2359-64. PubMed ID: 24684459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phalangeal quantitative ultrasound technology and dual energy X-ray densitometry in patients with primary hyperparathyroidism: influence of sex and menopausal status.
    Camozzi V; Lumachi F; Mantero F; Piccolo M; Luisetto G
    Osteoporos Int; 2003 Jul; 14(7):602-8. PubMed ID: 12730752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Periostin Levels are Significantly Higher in Patients with Primary Hyperparathyroidism and Closely Related to Osteoporosis.
    Yigitdol I; Gulumsek E; Ozturk HA; Arici FN; Akbal K; Pirinci O; Karacay M; Cihan TN; Totik ZG; Akyildiz MA; Avci BS; Avci A; Sumbul HE
    Exp Clin Endocrinol Diabetes; 2023 Sep; 131(9):449-455. PubMed ID: 37276863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silent renal stones in primary hyperparathyroidism: prevalence and clinical features.
    Cassibba S; Pellegrino M; Gianotti L; Baffoni C; Baralis E; Attanasio R; Guarnieri A; Borretta G; Tassone F
    Endocr Pract; 2014 Nov; 20(11):1137-42. PubMed ID: 24936557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.